{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:50:18Z","timestamp":1792691418989,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071157"],"award-info":[{"award-number":["32071157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.yjmcc.2023.05.005","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T14:07:56Z","timestamp":1685023676000},"page":"15-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Maresin-1 protects against pulmonary arterial hypertension by improving mitochondrial homeostasis through ALXR\/HSP90\u03b1 axis"],"prefix":"10.1016","volume":"181","author":[{"given":"Min","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenling","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejia","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youfei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangrui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.yjmcc.2023.05.005_bb0005","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.14336\/AD.2020.0111","article-title":"Pathological mechanisms and potential therapeutic targets of pulmonary arterial hypertension: a review","volume":"11","author":"Xiao","year":"2020","journal-title":"Aging Dis."},{"issue":"14","key":"10.1016\/j.yjmcc.2023.05.005_bb0010","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.2022.4402","article-title":"Diagnosis and treatment of pulmonary arterial hypertension: a review","volume":"327","author":"Ruopp","year":"2022","journal-title":"Jama."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.05.005_bb0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/bph.15016","article-title":"Current and future treatments of pulmonary arterial hypertension","volume":"178","author":"Sommer","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.yjmcc.2023.05.005_bb0020","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1089\/ars.2018.7705","article-title":"Mitochondrial dysfunction: metabolic drivers of pulmonary hypertension","volume":"31","author":"Suliman","year":"2019","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.05.005_bb0025","article-title":"Metabolism, mitochondrial dysfunction, and redox homeostasis in pulmonary hypertension","volume":"11","author":"Colon Hidalgo","year":"2022","journal-title":"Antioxidants (Basel)."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.05.005_bb0030","first-page":"L782","article-title":"Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both","volume":"314","author":"Marshall","year":"2018","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.05.005_bb0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/rccm.201505-0904ED","article-title":"Pulmonary arterial hypertension is associated with oxidative stress-induced genome instability","volume":"192","author":"Van Houten","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2023.05.005_bb0040","article-title":"Combination of Dichloroacetate and atorvastatin regulates excessive proliferation and oxidative stress in pulmonary arterial hypertension development via p38 signaling","volume":"2020","author":"Li","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.05.005_bb0045","first-page":"L40","article-title":"Decreased endothelial nitric oxide synthase expression and function contribute to impaired mitochondrial biogenesis and oxidative stress in fetal lambs with persistent pulmonary hypertension","volume":"310","author":"Afolayan","year":"2016","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"7","key":"10.1016\/j.yjmcc.2023.05.005_bb0050","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41419-022-05091-2","article-title":"FUNDC1-mediated mitophagy and HIF1\u03b1 activation drives pulmonary hypertension during hypoxia","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.yjmcc.2023.05.005_bb0055","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00109-017-1541-5","article-title":"MiR-125a regulates mitochondrial homeostasis through targeting mitofusin 1 to control hypoxic pulmonary vascular remodeling","volume":"95","author":"Ma","year":"2017","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.yjmcc.2023.05.005_bb0060","article-title":"Protective potential of Maresins in cardiovascular diseases","volume":"9","author":"Liu","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.yjmcc.2023.05.005_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106337","article-title":"Maresin-1 and its receptors ROR\u03b1\/LGR6 as potential therapeutic target for respiratory diseases","volume":"182","author":"Zhao","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.05.005_bb0070","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1096\/fj.14-265363","article-title":"Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice","volume":"29","author":"Akagi","year":"2015","journal-title":"FASEB J."},{"issue":"22","key":"10.1016\/j.yjmcc.2023.05.005_bb0075","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1111\/bph.15906","article-title":"Maresin 1 intervention reverses experimental pulmonary arterial hypertension in mice","volume":"179","author":"Li","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.yjmcc.2023.05.005_bb0080","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1172\/JCI129448","article-title":"Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions","volume":"129","author":"Chiang","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.05.005_bb0085","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1172\/JCI124219","article-title":"A maresin 1\/ROR\u03b1\/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis","volume":"129","author":"Han","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.05.005_bb0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s10020-021-00280-9","article-title":"Maresin 1 protects the liver against ischemia\/reperfusion injury via the ALXR\/Akt signaling pathway","volume":"27","author":"Tang","year":"2021","journal-title":"Mol. Med."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.05.005_bb0095","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41374-018-0031-x","article-title":"Maresin 1 attenuates mitochondrial dysfunction through the ALX\/cAMP\/ROS pathway in the cecal ligation and puncture mouse model and sepsis patients","volume":"98","author":"Gu","year":"2018","journal-title":"Lab. Investig."},{"issue":"6","key":"10.1016\/j.yjmcc.2023.05.005_bb0100","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/HYPERTENSIONAHA.121.17809","article-title":"Resolvin E1 attenuates pulmonary hypertension by suppressing Wnt7a\/\u03b2-catenin signaling","volume":"78","author":"Liu","year":"2021","journal-title":"Hypertension."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.05.005_bb0105","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1164\/rccm.201911-2137OC","article-title":"Loss of DP1 aggravates vascular remodeling in pulmonary arterial hypertension via mTORC1 signaling","volume":"201","author":"He","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2023.05.005_bb0110","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3389\/fnins.2020.00831","article-title":"Maresin 1 attenuates radicular pain through the inhibition of NLRP3 inflammasome-induced pyroptosis via NF-\u03baB signaling","volume":"14","author":"Wang","year":"2020","journal-title":"Front. Neurosci."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.05.005_bb0115","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.120.316784","article-title":"Niacin attenuates pulmonary hypertension through H-PGDS in macrophages","volume":"127","author":"Jia","year":"2020","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.yjmcc.2023.05.005_bb0120","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/nm.3695","article-title":"Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension","volume":"20","author":"Savai","year":"2014","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.05.005_bb0125","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1165\/rcmb.2016-0344OC","article-title":"Activation of Anoctamin-1 limits pulmonary endothelial cell proliferation via p38-mitogen-activated protein kinase-dependent apoptosis","volume":"58","author":"Allawzi","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"7","key":"10.1016\/j.yjmcc.2023.05.005_bb0130","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.119.316388","article-title":"Downregulation of LAPTM4B contributes to the impairment of the Autophagic flux via unopposed activation of mTORC1 signaling during myocardial ischemia\/reperfusion injury","volume":"127","author":"Gu","year":"2020","journal-title":"Circ. Res."},{"issue":"18","key":"10.1016\/j.yjmcc.2023.05.005_bb0135","doi-asserted-by":"crossref","first-page":"25652","DOI":"10.18632\/oncotarget.8357","article-title":"Tumor suppressor Spred2 interaction with LC3 promotes autophagosome maturation and induces autophagy-dependent cell death","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.05.005_bb0140","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002452R","article-title":"Postnatal deletion of Bmal1 in mice protects against obstructive renal fibrosis via suppressing Gli2 transcription","volume":"35","author":"Zhang","year":"2021","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.05.005_bb0145","article-title":"Plasma levels of proresolving and prophlogistic lipid mediators: association with severity of respiratory failure and mortality in acute respiratory distress syndrome","volume":"2","author":"Tejera","year":"2020","journal-title":"Crit. Care Explor."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.05.005_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13578-022-00744-3","article-title":"Ubiquitinated AIF is a major mediator of hypoxia-induced mitochondrial dysfunction and pulmonary artery smooth muscle cell proliferation","volume":"12","author":"Ma","year":"2022","journal-title":"Cell Biosci."},{"issue":"2","key":"10.1016\/j.yjmcc.2023.05.005_bb0155","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/j.2040-4603.2020.tb00125.x","article-title":"Mitochondria in the pulmonary vasculature in health and disease: oxygen-sensing, metabolism, and dynamics","volume":"10","author":"Dasgupta","year":"2020","journal-title":"Compr. Physiol."},{"issue":"13","key":"10.1016\/j.yjmcc.2023.05.005_bb0160","doi-asserted-by":"crossref","DOI":"10.1172\/JCI158447","article-title":"Mitochondrial dysfunction in cell senescence and aging","volume":"132","author":"Miwa","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2023.05.005_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.694702","article-title":"Molecular characterization and elucidation of pathways to identify novel therapeutic targets in pulmonary arterial hypertension","volume":"12","author":"Yao","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yjmcc.2023.05.005_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105287","article-title":"Resveratrol: mechanistic and therapeutic perspectives in pulmonary arterial hypertension","volume":"163","author":"Mirhadi","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.05.005_bb0175","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1164\/rccm.201708-1751OC","article-title":"Mitochondrial HSP90 accumulation promotes vascular remodeling in pulmonary arterial hypertension","volume":"198","author":"Boucherat","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"389","key":"10.1016\/j.yjmcc.2023.05.005_bb0180","doi-asserted-by":"crossref","first-page":"ra80","DOI":"10.1126\/scisignal.aab1624","article-title":"Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion","volume":"8","author":"Rivadeneira","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.yjmcc.2023.05.005_bb0185","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1038\/ncomms3139","article-title":"Landscape of the mitochondrial Hsp90 metabolome in tumours","volume":"4","author":"Chae","year":"2013","journal-title":"Nat. Commun."},{"issue":"18","key":"10.1016\/j.yjmcc.2023.05.005_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/cells11182778","article-title":"Targeting HSP90 as a novel therapy for cancer: mechanistic insights and translational relevance","volume":"11","author":"Zhang","year":"2022","journal-title":"Cells."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.05.005_bb0195","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1172\/JCI37613","article-title":"Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90","volume":"119","author":"Kang","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.05.005_bb0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20081880","article-title":"Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions","volume":"206","author":"Serhan","year":"2009","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.05.005_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031367","article-title":"Maresin-1 and inflammatory disease","volume":"23","author":"Saito-Sasaki","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.05.005_bb0210","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: an update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays Biochem."},{"key":"10.1016\/j.yjmcc.2023.05.005_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106151","article-title":"1,8-cineole ameliorates right ventricle dysfunction associated with pulmonary arterial hypertension by restoring connexin43 and mitochondrial homeostasis","volume":"180","author":"Alves-Silva","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.yjmcc.2023.05.005_bb0220","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.7150\/thno.55571","article-title":"Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function","volume":"11","author":"Lu","year":"2021","journal-title":"Theranostics."},{"key":"10.1016\/j.yjmcc.2023.05.005_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.782660","article-title":"Maresin 1 attenuates lipopolysaccharide-induced acute kidney injury via inhibiting NOX4\/ROS\/NF-\u03baB pathway","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.05.005_bb0230","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ame2.12220","article-title":"Experimental animal models of pulmonary hypertension: development and challenges","volume":"5","author":"Wu","year":"2022","journal-title":"Animal Model. Exp. Med."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.05.005_bb0235","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12272-020-01299-y","article-title":"Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm","volume":"44","author":"Lee","year":"2021","journal-title":"Arch. Pharm. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.05.005_bb0240","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/acsptsci.9b00075","article-title":"New advances in targeting the resolution of inflammation: implications for specialized pro-resolving mediator GPCR drug discovery","volume":"3","author":"Park","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.yjmcc.2023.05.005_bb0245","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3389\/fphys.2020.01081","article-title":"New insights into heat shock protein 90 in the pathogenesis of pulmonary arterial hypertension","volume":"11","author":"Hu","year":"2020","journal-title":"Front. Physiol."},{"issue":"34","key":"10.1016\/j.yjmcc.2023.05.005_bb0250","doi-asserted-by":"crossref","first-page":"54263","DOI":"10.18632\/oncotarget.10855","article-title":"Inhibition of heat shock protein 90 improves pulmonary arteriole remodeling in pulmonary arterial hypertension","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget."},{"issue":"16","key":"10.1016\/j.yjmcc.2023.05.005_bb0255","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1042\/BCJ20160005","article-title":"Mechanisms of Hsp90 regulation","volume":"473","author":"Prodromou","year":"2016","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.05.005_bb0260","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.onc.1210716","article-title":"The activity of hsp90 alpha promoter is regulated by NF-kappa B transcription factors","volume":"27","author":"Ammirante","year":"2008","journal-title":"Oncogene."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.05.005_bb0265","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41419-020-02846-7","article-title":"LXA(4)-FPR2 signaling regulates radiation-induced pulmonary fibrosis via crosstalk with TGF-\u03b2\/Smad signaling","volume":"11","author":"Kim","year":"2020","journal-title":"Cell Death Dis."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823000913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823000913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:37:57Z","timestamp":1758314277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282823000913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":53,"alternative-id":["S0022282823000913"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.05.005","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maresin-1 protects against pulmonary arterial hypertension by improving mitochondrial homeostasis through ALXR\/HSP90\u03b1 axis","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}